Utilization of gene profiling and proteomics to determine mineral pathogenicity in a human mesothelial cell line (LP9/TERT-1)

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 5-6, 2010, Pages 423-436

  Hillegass, Jedd M ^a   Shukla, Arti ^a   MacPherson, Maximilian B ^a   Bond, Jeffrey P ^b   Steele, Chad ^c   Mossman, Brooke T ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BASIC FIBROBLAST GROWTH FACTOR; CROCIDOLITE; GLASS; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 13; TALC; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CELL LEVEL; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA FINGERPRINTING; GENE EXPRESSION; HUMAN; HUMAN CELL; MESOTHELIOMA; MESOTHELIUM CELL; OVARY CELL; PATHOGENICITY; PREDICTION; PRIORITY JOURNAL; PROTEOMICS;

ASBESTOS, CROCIDOLITE; CELL LINE; EPITHELIUM; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-13; PARTICULATE MATTER; PROTEOMICS; TALC; TELOMERASE; TITANIUM; TOXICITY TESTS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77149177975     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903486568     Document Type: Article

References (76)

1. Amati, M., Tomasetti, M., Mariotti, L., Tarquini, L. M., Valentino, M., and Santarelli, L. 2008. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk. Mutat Res 655(1-2):52-58.
2. Aoe, K., Hiraki, A., Tanaka, T., Gemba, K., Taguchi, K., Murakami, T., Sueoka, N., Kamei, T., Ueoka, H., Sugi, K., Yoshino, T., and Kishimoto, T. 2006. Expression of vascular endothelial growth factor in malignant mesothelioma. Anticancer Res. 26(6C): 4833-4836.
3. Belitskaya-Levy, I., Hajjou, M., Su, W. C., Yie, T. A., Tchou-Wong, K. M., Tang, M. S., Goldberg, J. D., and Rom, W. N. 2007. Gene profiling of normal human bronchial epithelial cells in response to asbestos and benzo(a)pyrene diol epoxide (BPDE). J. Environ. Pathol. Toxicol. Oncol. 26(4):281-294.
4. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2):185-193.
5. Bremnes, R. M., Camps, C., and Sirera, R. 2006. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51(2):143-158.
6. Buder-Hoffmann, S. A., Shukla, A., Barrett, T. F., Macpherson, M. B., Lounsbury, K. M., and Mossman, B. T. 2008. A protein kinase C{delta}-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos. Am J Pathol 174(2):449-459.
7. Catalano, A., Gianni, W., and Procopio, A. 2004. Experimental therapy of malignant mesothelioma: New perspectives from antiangiogenic treatments. Crit. Rev. Oncol. Hematol. 50(2):101-109.
8. Choi, J. H., Choi, K. C., Auersperg, N., and Leung, P. C. 2004. Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 89(11):5508-5516.
9. Committee on Asbestos: Selected Health Effects. 2006. Asbestos: Selected cancers, ed. North American Institute of Medicine. Washington, DC: National Academies Press.
10. Davidson, B., Risberg, B., Berner, A., Bedrossian, C. W., and Reich, R. 2006. The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma. Semin. Diagn. Pathol. 23(1):35-43. (Pubitemid 44430047)
11. Davidson, B., Vintman, L., Zcharia, E., Bedrossian, C., Berner, A., Nielsen, S., Ilan, N., Vlodavsky, I., and Reich, R. 2004. Heparanase and basic fibroblast growth factor are coexpressed in malignant mesothelioma. Clin. Exp. Metastasis 21(5):469-476.
12. Demetri, G. D., Zenzie, B. W., Rheinwald, J. G., and Griffin, J. D. 1989. Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74(3):940-946.
13. Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., and Rheinwald, J. G. 2000. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell Biol. 20(4):1436-1447.
14. Donaldson, K., Li, X. Y., Dogra, S., Miller, B. G., and Brown, G. M. 1992. Asbestos-stimulated tumour necrosis factor release from alveolar macrophages depends on fibre length and opsonization. J. Pathol. 168(2):243-248.
15. Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., and Tschopp, J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320(5876):674-677.
16. Elias, J. A., Lee, C. G., Zheng, T., Shim, Y., and Zhu, Z. 2003. Interleukin-13 and leukotrienes: An intersection of pathogenetic schema. Am. J. Respir. Cell Mol. Biol. 28(4):401-404.
17. Hansen, K., and Mossman, B. T. 1987. Generation of superoxide (O2 -.) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res. 47(6): 1681-1686.
18. Hansen, S. F., Michelson, E. S., Kamper, A., Borling, P., Stuer-Lauridsen, F., and Baun, A. 2008. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17(5): 438-447.
19. Hevel, J. M., Olson-Buelow, L. C., Ganesan, B., Stevens, J. R., Hardman, J. P., and Aust, A. E. 2008. Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics 9:376.
20. Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M., Hobbs, B., and Speed, T. P. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31(4):e15.
21. Irizarry, R. A., Gautier, L., Bolstad, B. M., Miller, C., Astrand, M., Cope, L. M., Gentleman, R., Gentry, J., Halling, C., Huber, W., MacDonald, J., Rubinstein, B. I. P., Workman, C., and Zhang, J. 2007. affy: Methods for Affymetrix Oligonucleotide Arrays. 1.14.1 (R package version). http:// www.bioconductor.org
22. Iwakawa, M., Hamada, N., Imadome, K., Funayama, T., Sakashita, T., Kobayashi Y., and Imai, T. 2008. Expression profiles are different in carbon ion-irradiated normal human fibroblasts and their bystander cells. Mutat. Res. 642(1-2):57-67.
23. Janssen, Y. M., Heintz, N. H., and Mossman, B. T. 1995. Induction of c-fos and c-jun protooncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res. 55(10):2085-2089.
24. Jolliffe, I. 1986. Principal component analysis. New York: Springer Verlag.
25. Kamp, D. W., and Weitzman, S. A. 1999. The molecular basis of asbestos induced lung injury. Thorax 54(7):638-652.
26. Karoly, E. D., Li, Z., Dailey, L. A., Hyseni, X., and Huang, Y. C. 2007. Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure. Environ. Health Perspect. 115(4):535-540.
27. Kasuga, I., Ishizuka, S., Minemura, K., Utsumi, K., Serizawa, H., and Ohyashiki, K. 2001. Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor. Chest 119(3):981-983.
28. Kimura, N., Ogasawara, T., Asonuma, S., Hama, H., Sawai, T., and Toyota, T. 2005. Granulocyte-colony stimulating factor- and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma. Mod. Pathol. 18(3):446-450.
29. Kindler, H. L. 2004. Moving beyond chemotherapy: Novel cytostatic agents for malignant mesothelioma. Lung Cancer 45(suppl. 1): S125-S127.
30. Kong, W., Vanderburg, C., Gunshin, H., Rogers, J., and Huang, X. 2008. A review of independent component analysis application to microarray gene expression data. Biotechniques 45(5):501-520.
31. Kumar-Singh, S., Weyler, J., Martin, M. J., Vermeulen, P. B., and Van Marck, E. 1999. Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1 and -2, and TGF beta expression. J. Pathol. 189(1):72-78.
32. Lake, R. A., and Robinson, B. W. 2005. Immunotherapy and chemotherapy-A practical partnership. Nat Rev Cancer 5(5):397-405.
33. Lee, P. J., Zhang, X., Shan, P., Ma, B., Lee, C. G., Homer, R. J., Zhu, Z., Rincon, M., Mossman, B. T., and Elias, J. A. 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 116(1):163-173.
34. Lemaire, I., and Ouellet, S. 1996. Distinctive profile of alveolar macrophage-derived cytokine release induced by fibrogenic and nonfibrogenic mineral dusts. J. Toxicol. Environ. Health 47(5):465-478.
35. Linder, C., Linder, S., Munck-Wikland, E., and Strander, H. 1998. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. Anticancer Res. 18(3B):2063-2068.
36. Liu, J. Y., Brass, D. M., Hoyle, G. W., and Brody, A. R. 1998. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am. J. Pathol. 153(6):1839-1847.
37. Lund, L. G., and Aust, A. E. 1992. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in phi X174 RFI DNA. Carcinogenesis 13(4):637-642.
38. Lund, L. G., Williams, M. G., Dodson, R. F., and Aust, A. E. 1994. Iron associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA. Occup. Environ. Med. 51(3):200-204.
39. Manning, C. B., Vallyathan, V., and Mossman, B. T. 2002. Diseases caused by asbestos: Mechanisms of injury and disease development. Int. Immunopharmacol. 2(2-3):191-200. (Pubitemid 34075410)
40. Masood, R., Kundra, A., Zhu, S., Xia, G., Scalia, P., Smith, D. L., and Gill, P. S. 2003. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 104(5):603-610.
41. Merritt, M. A., Green, A. C., Nagle, C. M., and Webb, P. M. 2008. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int. J. Cancer 122(1):170-176.
42. Miyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J. A., Piguet, P. F., and Vassalli, P. 1995. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96(1):250-259.
43. Mossman, B. T., Bignon, J., Corn, M., Seaton, A., and Gee, J. B. 1990. Asbestos: Scientific developments and implications for public policy. Science 247(4940):294-301. (Pubitemid 20046453)
44. Mossman, B. T., and Churg, A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157(5 Pt 1):1666-1680.
45. Mossman, B. T., and Gee, J. B. 1989. Asbestosrelated diseases. N. Engl. J. Med. 320(26):1721-1730.
46. Muramatsu, T., and Muramatsu, H. 2008. Glycosaminoglycan-binding cytokines as tumor markers. Proteomics 8(16):3350-3359.
47. Nishimura, M., Itoh, K., Ito, K., Yanada, M., Terauchi, K., Fushiki, S., and Shimada, J. 2006. Autocrine growth by granulocyte colony-stimulating factor in malignant mesothelioma. Ann. Thoracic Surg. 82(5):1904-1906.
48. Nowak, A. K., Lake, R. A., Kindler, H. L., and Robinson, B. W. 2002. New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agents. Semin. Oncol. 29(1):82-96.
49. Nymark, P., Lindholm, P. M., Korpela, M. V., Lahti, L., Ruosaari, S., Kaski, S., Hollmen, J., Anttila, S., Kinnula, V. L., and Knuutila, S. 2007. Gene expression profiles in asbestosexposed epithelial and mesothelial lung cell lines. BMC Genomics 8:62.
50. Ohbayashi, H., Nosaka, H., Hirose, K., Yamase, H., Yamaki, K., and Ito, M. 1999. Granulocyte colony stimulating factor-producing diffuse malignant mesothelioma of pleura. Intern. Med. 38(8):668-670.
51. R Development Core Team. 2007. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Available at http://cran.r-project.org/doc/manuals/ refman.pdf
52. Ramos-Nino, M. E., Heintz, N., Scappoli, L., Martinelli, M., Land, S., Nowak, N., Haegens, A., Manning, B., Manning, N., MacPherson, M., Stern, M., and Mossman, B. 2003. Gene profiling and kinase screening in asbestos-exposed epithelial cells and lungs. Am. J. Respir. Cell Mol. Biol. 29(3 suppl.):S51-S58.
53. Reid, A., Segal, A., Heyworth, J. S., de Klerk, N. H., and Musk, A. W. 2009. Gynecologic and breast cancers in women after exposure to blue asbestos at Wittenoom. Cancer Epidemiol. Biomarkers Prev. 18(1): 140-147.
54. Robledo, R., and Mossman, B. 1999. Cellular and molecular mechanisms of asbestosinduced fibrosis. J. Cell Physiol. 180(2): 158-166.
55. Ruco, L. P., De Laat, P. A., Matteucci, C., Bernasconi, S., Sciacca, F. M., Van Der Kwast, T. H., Hoogsteden, H. C., Uccini, S., Mantovani, A., and Versnel, M. A. 1996. Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J. Pathol. 179(3):266-271.
56. Ruosaari, S., Hienonen-Kempas, T., Puustinen, A., Sarhadi, V. K.,Hollmen, J., Knuutila, S., Saharinen, J., Wikman, H., and Anttila, S. 2008. Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients. BMC Med. Genomics 1:55.
57. Sabo-Attwood, T., Ramos-Nino, M., Bond, J., Butnor, K. J., Heintz, N., Gruber, A. D., Steele, C., Taatjes, D. J., Vacek, P., and Mossman, B. T. 2005. Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am. J. Pathol. 167(5):1243-1256.
58. Schmitter, D., Lauber, B., Fagg, B., and Stahel, R. A. 1992. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin-6 production as a common feature. Int. J. Cancer 51(2):296-301.
59. Schulte, P., Geraci, C., Zumwalde, R., Hoover, M., and Kuempel, E. 2008. Occupational risk management of engineered nanoparticles. J. Occup. Environ. Hyg. 5(4):239-249.
60. Shukla, A., Flanders, T., Lounsbury, K. M., and Mossman, B. T. 2004. The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity. Cancer Res. 64(21):7780-7786.
61. Shukla, A., Jung, M., Stern, M., Fukagawa, N. K., Taatjes, D. J., Sawyer, D., Van Houten, B., and Mossman, B. T. 2003a. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 285(5):L1018-L1025.
62. Shukla, A., Lounsbury, K. M., Barrett, T. F., Gell, J., Rincon, M., Butnor, K. J., Taatjes, D. J., Davis, G. S., Vacek, P., Nakayama, K. I., Nakayama, K., Steele, C., and Mossman, B. T. 2007. Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice. Am. J. Pathol. 170(1):140-151.
63. Shukla, A., Macpherson, M. B., Hillegass, J., Ramos-Nino, M. E., Alexeeva, V., Vacek, P. M., Bond, J. P., Pass, H. I., Steele, C., and Mossman, B. T. 2008. Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity. Am. J. Respir. Cell Mol. Biol. 41(1):114-123.
64. Shukla, A., Stern, M., Lounsbury, K. M., Flanders, T., and Mossman, B. T. 2003b. Asbestos-induced apoptosis is protein kinase C delta-dependent. Am. J. Respir. Cell Mol. Biol. 29(2):198-205.
65. Simeonova, P. P., and Luster, M. I. 1995. Iron and reactive oxygen species in the asbestosinduced tumor necrosis factor-alpha response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12(6): 676-683.
66. Smyth, G. K. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:article 3.
67. Smyth, G. K. 2005. Limma: Linear models for microarray data. In Bioinformatics and computational biology solutions using R and Bioconductor, eds. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber, pp. 397-420. New York: Springer.
68. Steiner, G., Suter, L., Boess, F., Gasser, R., De Vera, M. C., Albertini, S., and Ruepp, S. 2004. Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. 112(12):1236-1248.
69. Stevens, T., Krantz, Q. T., Linak, W. P., Hester, S., and Gilmour, M. I. 2008. Increased transcription of immune and metabolic pathways in naive and allergic mice exposed to diesel exhaust. Toxicol. Sci. 102(2):359-370.
70. Strizzi, L., Catalano, A., Vianale, G., Orecchia, S., Casalini, A., Tassi, G., Puntoni, R., Mutti, L., and Procopio, A. 2001. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol. 193(4):468-475. (Pubitemid 32266815)
71. Terabe, M., Park, J. M., and Berzofsky, J. A. 2004. Role of IL-13 in regulation of antitumor immunity and tumor growth. Cancer Immunol. Immunother. 53(2):79-85.
72. Vallyathan, V., Mega, J. F., Shi, X., and Dalal, N. S. 1992. Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am. J. Respir. Cell Mol. Biol. 6(4):404-413.
73. Wang, Y., Faux, S. P., Hallden, G., Kirn, D. H., Houghton, C. E., Lemoine, N. R., and Patrick, G. 2004. Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite. Int. J. Oncol. 25(1):173-178.
74. Worley, L. A., Long, M. D., Onken, M. D., and Harbour, J. W. 2008. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res. 18(3):184-190.
75. Yang, H., Testa, J. R., and Carbone, M. 2008. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr. Treat. Options Oncol. 9(2-3):147-157.
76. Yoshimoto, A., Kasahara, K., Saito, K., Fujimura, M., and Nakao, S. 2005. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines. Int. J. Clin. Oncol. 10(1):58-62.